The Impact of Nicotinamide Mononucleotide Sustained-release Tablets on Immunosenescence and Metablism in Middle-aged and Elderly Individuals With Metabolic Disorders.
Clinical trial NCT06907329 · RECRUITING
Trial details
- NCT number
- NCT06907329
- Sponsor
- Qing Su
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-05
- Primary completion
- 2027-03-31
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.